Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 9, 2010

Premium

Arrowhead Research, the parent firm of Calando Pharmaceuticals, said that Douglass Given has joined its board of directors.

Given is currently chairman and CEO of Vivaldi Biosciences, chairman of Via Pharmaceuticals, and an investment partner at Bay City Capital.


Alnylam Pharmaceuticals has appointed Marsha Fanucci to its board of directors.

Fanucci is the former CFO of Millennium Pharmaceuticals, and currently sits on the board of Ironwood Pharmaceuticals and Momenta Pharmaceuticals.

She previously served as vice president of corporate development and strategy at Genzyme.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.